Prestige Consumer Healthcare Inc (PBH)

Currency in USD
74.65
-1.65(-2.16%)
Closed·
After Hours
74.65+0.01(+0.01%)
·

PBH Earnings

Latest Release
May 08, 2025
EPS / Forecast
1.00 / 1.30
Revenue / Forecast
296.52M / 291.17M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/1--/261M----Free Sign Up
03/20251/1.3296.52M/291.17M-23.08%+1.84%Free Sign Up
12/20241.22/1.16290.3M/287.07M+5.17%+1.13%Free Sign Up
09/20241.09/1.08283.8M/282.17M+0.93%+0.58%Free Sign Up
06/20240.9/0.86267.14M/260.42M+4.65%+2.58%Free Sign Up
03/20241.02/1.02276.99M/276.99M0%0%Free Sign Up
12/20231.06/1.04282.7M/280.25M+1.92%+0.87%Free Sign Up
09/20231.07/1.07286.3M/285.22M0%+0.38%Free Sign Up
06/20231.06/1.06279.31M/279.31M0%0%Free Sign Up
03/2023-4.83/1.04285.9M/278.94M-564.42%+2.5%Free Sign Up

All numbers in USD

Prestige Consumer Healthcare Inc Earnings Call Summary for Q4/2024

  • Prestige Consumer Healthcare expects $830M revenue gain for 2025, with $500M organic growth and 2-3% volume growth in Canada
  • Four recent acquisitions and a new Tennessee facility set to boost product offerings and production capacity significantly
  • Strong financial health with EBITDA of $361.26M and 55.9% gross profit margin; stock near 52-week high at $84.36
  • U.S. growth pipeline strong with $1.4B potential opportunities; 2027 targets reiterated despite paused dividend increases
  • CEO confident in growth trajectory; CFO addresses financial structure concerns amid increased inventory days and CapEx requirements
Last Updated: 21/03/2025, 19:36
Read Full Transcript

FAQ

What Is Prestige Consumer Health's Earnings Per Share (TTM)?

The Prestige Consumer Health EPS (TTM) is 4.32.

When Is The Next Prestige Consumer Health Earnings Date?

Prestige Consumer Health will release its next earnings report on 06 Aug 2025.

What Is Prestige Consumer Health’s Revenue Forecasts For Upcoming Quarters?

Prestige Consumer Health’s revenue forecast is 261.00M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.